Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 342

1.

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, Hawkins J, Birnbaum J, Lyons DM, Rodriguez CI, Schatzberg AF.

Am J Psychiatry. 2018 Aug 29:appiajp201818020138. doi: 10.1176/appi.ajp.2018.18020138. [Epub ahead of print]

PMID:
30153752
2.

Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders.

Roat-Shumway S, Wroolie TE, Watson K, Schatzberg AF, Rasgon NL.

J Affect Disord. 2018 Oct 15;239:242-246. doi: 10.1016/j.jad.2018.07.014. Epub 2018 Jul 10.

PMID:
30025313
3.

Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis.

Hagenauer MH, Schulmann A, Li JZ, Vawter MP, Walsh DM, Thompson RC, Turner CA, Bunney WE, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H.

PLoS One. 2018 Jul 17;13(7):e0200003. doi: 10.1371/journal.pone.0200003. eCollection 2018.

4.

Learning to actively cope with stress in female mice.

Lyons DM, Buckmaster CL, Schatzberg AF.

Psychoneuroendocrinology. 2018 Oct;96:78-83. doi: 10.1016/j.psyneuen.2018.06.010. Epub 2018 Jun 9.

PMID:
29909293
5.

Connective Tissue Growth Factor Is a Novel Prodepressant.

Turner CA, Sharma V, Hagenauer MH, Chaudhury S, O'Connor AM, Hebda-Bauer EK, Thompson RC, Myers RM, Bunney WE, Barchas JD, Lee FS, Schatzberg AF, Watson SJ Jr, Akil H.

Biol Psychiatry. 2018 May 3. pii: S0006-3223(18)31468-9. doi: 10.1016/j.biopsych.2018.04.013. [Epub ahead of print]

PMID:
29861095
6.

Neural cell adhesion molecule peptide mimetics modulate emotionality: pharmacokinetic and behavioral studies in rats and non-human primates.

Turner CA, Lyons DM, Buckmaster CL, Aurbach EL, Watson SJ, Schatzberg AF, Akil H.

Neuropsychopharmacology. 2018 Apr 9. doi: 10.1038/s41386-018-0052-6. [Epub ahead of print]

PMID:
29703997
7.

Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Rollins BL, Morgan L, Hjelm BE, Sequeira A, Schatzberg AF, Barchas JD, Lee FS, Myers RM, Watson SJ, Akil H, Potkin SG, Bunney WE, Vawter MP.

Mol Neuropsychiatry. 2018 Feb;3(3):157-169. doi: 10.1159/000484348. Epub 2017 Nov 30.

PMID:
29594135
8.

High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression.

Williams NR, Sudheimer KD, Bentzley BS, Pannu J, Stimpson KH, Duvio D, Cherian K, Hawkins J, Scherrer KH, Vyssoki B, DeSouza D, Raj KS, Keller J, Schatzberg AF.

Brain. 2018 Feb 5. doi: 10.1093/brain/awx379. [Epub ahead of print] No abstract available.

PMID:
29415152
9.

The Black Book of Psychotropic Dosing and Monitoring.

Schatzberg AF, Charles D.

Psychopharmacol Bull. 2018 Jan 15;48(1):64-153. No abstract available.

PMID:
29382960
10.

Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression.

Davis EG, Keller J, Hallmayer J, Pankow HR, Murphy GM Jr, Gotlib IH, Schatzberg AF.

Transl Psychiatry. 2018 Jan 10;8(1):5. doi: 10.1038/s41398-017-0051-0. Review.

11.

Quantitative validation of immunofluorescence and lectin staining using reduced CLARITY acrylamide formulations.

Krolewski DM, Kumar V, Martin B, Tomer R, Deisseroth K, Myers RM, Schatzberg AF, Lee FS, Barchas JD, Bunney WE, Akil H, Watson SJ Jr.

Brain Struct Funct. 2018 Mar;223(2):987-999. doi: 10.1007/s00429-017-1583-z. Epub 2017 Dec 14.

PMID:
29243106
12.

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.

O'Connell CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, Debattista C, Carrillo-Roa T, Binder EB, Dunlop BW, Craighead WE, Mayberg HS, Williams LM.

Am J Psychiatry. 2018 Mar 1;175(3):251-261. doi: 10.1176/appi.ajp.2017.17020172. Epub 2017 Dec 15.

PMID:
29241359
13.

Stress amplifies sex differences in primate prefrontal profiles of gene expression.

Lee AG, Hagenauer M, Absher D, Morrison KE, Bale TL, Myers RM, Watson SJ, Akil H, Schatzberg AF, Lyons DM.

Biol Sex Differ. 2017 Nov 2;8(1):36. doi: 10.1186/s13293-017-0157-3.

14.

Post-mortem molecular profiling of three psychiatric disorders.

Ramaker RC, Bowling KM, Lasseigne BN, Hagenauer MH, Hardigan AA, Davis NS, Gertz J, Cartagena PM, Walsh DM, Vawter MP, Jones EG, Schatzberg AF, Barchas JD, Watson SJ, Bunney BG, Akil H, Bunney WE, Li JZ, Cooper SJ, Myers RM.

Genome Med. 2017 Jul 28;9(1):72. doi: 10.1186/s13073-017-0458-5.

15.

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.

Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments.

JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080. Review.

PMID:
28249076
16.

Erratum: Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C.

Nat Med. 2017 Feb 7;23(2):264. doi: 10.1038/nm0217-264d. No abstract available.

17.

Side Effects to Antidepressant Treatment in Patients With Depression and Comorbid Panic Disorder.

Shankman SA, Gorka SM, Katz AC, Klein DN, Markowitz JC, Arnow BA, Manber R, Rothbaum BO, Thase ME, Schatzberg AF, Keller MB, Trivedi MH, Kocsis JH.

J Clin Psychiatry. 2017 Apr;78(4):433-440. doi: 10.4088/JCP.15m10370.

PMID:
28068460
18.

Striatal dopamine D2/3 receptor regulation by stress inoculation in squirrel monkeys.

Lee AG, Nechvatal JM, Shen B, Buckmaster CL, Levy MJ, Chin FT, Schatzberg AF, Lyons DM.

Neurobiol Stress. 2016 Feb 8;3:68-73. eCollection 2016 Jun.

19.

Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder.

Mamdani F, Rollins B, Morgan L, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Potkin SG, Bunney WE, Vawter MP, Sequeira PA.

Transl Psychiatry. 2016 Dec 6;6(12):e969. doi: 10.1038/tp.2015.164. No abstract available.

20.

Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C.

Nat Med. 2017 Jan;23(1):28-38. doi: 10.1038/nm.4246. Epub 2016 Dec 5. Erratum in: Nat Med. 2017 Feb 7;23 (2):264.

21.

Eberhard H Uhlenhuth.

Schatzberg AF, Keith SJ.

Neuropsychopharmacology. 2016 Dec;41(13):3127. doi: 10.1038/npp.2016.132. No abstract available.

22.

Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants.

Goldstein-Piekarski AN, Korgaonkar MS, Green E, Suppes T, Schatzberg AF, Hastie T, Nemeroff CB, Williams LM.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11955-11960. Epub 2016 Oct 10.

23.

Major depressive disorder.

Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF.

Nat Rev Dis Primers. 2016 Sep 15;2:16065. doi: 10.1038/nrdp.2016.65. Review.

PMID:
27629598
24.

HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.

Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM Jr, Schatzberg AF.

Mol Psychiatry. 2017 Apr;22(4):527-536. doi: 10.1038/mp.2016.120. Epub 2016 Aug 16.

25.

The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression.

Azevedo JA, Carter BS, Meng F, Turner DL, Dai M, Schatzberg AF, Barchas JD, Jones EG, Bunney WE, Myers RM, Akil H, Watson SJ, Thompson RC.

J Psychiatr Res. 2016 Nov;82:58-67. doi: 10.1016/j.jpsychires.2016.07.012. Epub 2016 Jul 18.

26.

WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN?

Newport DJ, Schatzberg AF, Nemeroff CB.

Depress Anxiety. 2016 Aug;33(8):685-8. doi: 10.1002/da.22535. No abstract available.

PMID:
27459676
27.

Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research.

Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AFT, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA Jr, Carter CS, Cook EH Jr, Daskalakis ZJ, DiLeone RJ, Duman RS, Grace AA, Hariri AR, Harrison PJ, Hiroi N, Kenny PJ, Kleinman JE, Krystal AD, Lewis DA, Lipska BK, Marder SR, Mason GF, Mathalon DH, McClung CA, McDougle CJ, McIntosh AM, McMahon FJ, Mirnics K, Monteggia LM, Narendran R, Nestler EJ, Neumeister A, O'Donovan MC, Öngür D, Pariante CM, Paulus MP, Pearlson G, Phillips ML, Pine DS, Pizzagalli DA, Pletnikov MV, Ragland JD, Rapoport JL, Ressler KJ, Russo SJ, Sanacora G, Sawa A, Schatzberg AF, Shaham Y, Shamay-Tsoory SG, Sklar P, State MW, Stein MB, Strakowski SM, Taylor SF, Turecki G, Turetsky BI, Weissman MM, Zachariou V, Zarate CA Jr, Zubieta JK.

Biol Psychiatry. 2016 Jul 15;80(2):84-86. doi: 10.1016/j.biopsych.2016.05.004. No abstract available.

PMID:
27346079
28.

Anhedonia and general distress show dissociable ventromedial prefrontal cortex connectivity in major depressive disorder.

Young CB, Chen T, Nusslock R, Keller J, Schatzberg AF, Menon V.

Transl Psychiatry. 2016 May 17;6:e810. doi: 10.1038/tp.2016.80.

29.

Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.

Williams LM, Debattista C, Duchemin AM, Schatzberg AF, Nemeroff CB.

Transl Psychiatry. 2016 May 3;6:e799. doi: 10.1038/tp.2016.61.

30.

Learning to cope with stress modulates anterior cingulate cortex stargazin expression in monkeys and mice.

Lee AG, Capanzana R, Brockhurst J, Cheng MY, Buckmaster CL, Absher D, Schatzberg AF, Lyons DM.

Neurobiol Learn Mem. 2016 May;131:95-100. doi: 10.1016/j.nlm.2016.03.015. Epub 2016 Mar 18.

31.

Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders.

Morgan LZ, Rollins B, Sequeira A, Byerley W, DeLisi LE, Schatzberg AF, Barchas JD, Myers RM, Watson SJ, Akil H, Bunney WE Jr, Vawter MP.

Microarrays (Basel). 2016 Mar;5(1). pii: 6. Epub 2016 Mar 7.

32.

Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression ("RAD") project.

Williams LM, Goldstein-Piekarski AN, Chowdhry N, Grisanzio KA, Haug NA, Samara Z, Etkin A, O'Hara R, Schatzberg AF, Suppes T, Yesavage J.

BMC Psychiatry. 2016 Mar 15;16:68. doi: 10.1186/s12888-016-0771-3.

33.

NMDA antagonist treatment of depression.

Williams NR, Schatzberg AF.

Curr Opin Neurobiol. 2016 Feb;36:112-7. doi: 10.1016/j.conb.2015.11.001. Epub 2015 Dec 11. Review.

PMID:
26687375
34.

Opioids in Psychiatric Disorders: Back to the Future?

Schatzberg AF.

Am J Psychiatry. 2016 Jun 1;173(6):564-5. doi: 10.1176/appi.ajp.2015.15101354. Epub 2015 Dec 18. No abstract available.

PMID:
26684924
35.

Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder.

Mamdani F, Rollins B, Morgan L, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Potkin SG, Bunney WE, Vawter MP, Sequeira PA.

Transl Psychiatry. 2015 Sep 15;5:e636. doi: 10.1038/tp.2015.134. Erratum in: Transl Psychiatry. 2016 Dec 6;6(12 ):e969.

36.

Fibroblast growth factor 9 is a novel modulator of negative affect.

Aurbach EL, Inui EG, Turner CA, Hagenauer MH, Prater KE, Li JZ, Absher D, Shah N, Blandino P Jr, Bunney WE, Myers RM, Barchas JD, Schatzberg AF, Watson SJ Jr, Akil H.

Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11953-8. doi: 10.1073/pnas.1510456112. Epub 2015 Sep 8.

37.

Development of New Psychopharmacological Agents for Depression and Anxiety.

Schatzberg AF.

Psychiatr Clin North Am. 2015 Sep;38(3):379-93. doi: 10.1016/j.psc.2015.05.009. Review.

PMID:
26300029
38.

Career Development Institute with Enhanced Mentoring: A Revisit.

Kupfer DJ, Schatzberg AF, Dunn LO, Schneider AK, Moore TL, DeRosier M.

Acad Psychiatry. 2016 Jun;40(3):424-8. doi: 10.1007/s40596-015-0362-5. Epub 2015 Jun 6.

39.

Mitochondrial mutations in subjects with psychiatric disorders.

Sequeira A, Rollins B, Magnan C, van Oven M, Baldi P, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Bunney WE, Vawter MP.

PLoS One. 2015 May 26;10(5):e0127280. doi: 10.1371/journal.pone.0127280. eCollection 2015.

40.

Stress inoculation modeled in mice.

Brockhurst J, Cheleuitte-Nieves C, Buckmaster CL, Schatzberg AF, Lyons DM.

Transl Psychiatry. 2015 Mar 31;5:e537. doi: 10.1038/tp.2015.34.

41.

ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.

Schatzberg AF, DeBattista C, Lazzeroni LC, Etkin A, Murphy GM Jr, Williams LM.

Am J Psychiatry. 2015 Aug 1;172(8):751-9. doi: 10.1176/appi.ajp.2015.14050680. Epub 2015 Mar 27.

PMID:
25815420
42.

Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.

Arnow BA, Blasey C, Williams LM, Palmer DM, Rekshan W, Schatzberg AF, Etkin A, Kulkarni J, Luther JF, Rush AJ.

Am J Psychiatry. 2015 Aug 1;172(8):743-50. doi: 10.1176/appi.ajp.2015.14020181. Epub 2015 Mar 27.

PMID:
25815419
43.

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Sanacora G, Schatzberg AF.

Neuropsychopharmacology. 2015 Mar 13;40(5):1307. doi: 10.1038/npp.2014.338. No abstract available.

44.

Issues encountered in recent attempts to develop novel antidepressant agents.

Schatzberg AF.

Ann N Y Acad Sci. 2015 May;1345:67-73. doi: 10.1111/nyas.12716. Epub 2015 Mar 11. Review.

PMID:
25762133
45.

Cognitive and emotional biomarkers of melancholic depression: An iSPOT-D report.

Day CV, Gatt JM, Etkin A, DeBattista C, Schatzberg AF, Williams LM.

J Affect Disord. 2015 May 1;176:141-50. doi: 10.1016/j.jad.2015.01.061. Epub 2015 Feb 7.

PMID:
25710095
46.

The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.

Saveanu R, Etkin A, Duchemin AM, Goldstein-Piekarski A, Gyurak A, Debattista C, Schatzberg AF, Sood S, Day CV, Palmer DM, Rekshan WR, Gordon E, Rush AJ, Williams LM.

J Psychiatr Res. 2015 Feb;61:1-12. doi: 10.1016/j.jpsychires.2014.12.018. Epub 2014 Dec 31.

PMID:
25586212
47.

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.

Sarginson JE, Killen JD, Lazzeroni LC, Fortmann SP, Ryan HS, Ameli N, Schatzberg AF, Murphy GM Jr.

Nicotine Tob Res. 2015 Sep;17(9):1126-33. doi: 10.1093/ntr/ntu273. Epub 2015 Jan 8.

48.

Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report.

Day CV, John Rush A, Harris AW, Boyce PM, Rekshan W, Etkin A, DeBattista C, Schatzberg AF, Arnow BA, Williams LM.

J Affect Disord. 2015 Mar 15;174:493-502. doi: 10.1016/j.jad.2014.10.046. Epub 2014 Nov 7.

PMID:
25554994
49.

An overview of vortioxetine.

Schatzberg AF, Blier P, Culpepper L, Jain R, Papakostas GI, Thase ME.

J Clin Psychiatry. 2014 Dec;75(12):1411-8. doi: 10.4088/JCP.14027ah1. Review.

50.

A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.

Etkin A, Patenaude B, Song YJ, Usherwood T, Rekshan W, Schatzberg AF, Rush AJ, Williams LM.

Neuropsychopharmacology. 2015 May;40(6):1332-42. doi: 10.1038/npp.2014.333. Epub 2014 Dec 30.

Supplemental Content

Loading ...
Support Center